{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:24:17Z","timestamp":1780575857345,"version":"3.54.1"},"reference-count":41,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["Innovative Research Award"],"award-info":[{"award-number":["Innovative Research Award"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2024,6,27]]},"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Contraception is crucial for safely timing pregnancies in patients with SLE. This study investigated predictors of contraception documentation in patients with SLE, and the alignment of contraception practices with the 2020 American College of Rheumatology (ACR) guidelines, within the Rheumatology Informatics System for Effectiveness (RISE) registry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and methods<\/jats:title>\n                  <jats:p>Female patients (aged 18\u201344 years) with SLE were identified via International Classification of Diseases (ICD)-9\/ICD-10 coding within the RISE registry, which includes data from rheumatology clinics across the USA. Eligible patients were required to have \u22651 clinical visit in 2019 (prepandemic) or between 1 April 2020 and 30 March 2021 (mid-pandemic). Adjusted multilevel logistic modelling assessed patient, provider and practice characteristics for associations with contraception documentation. Contraception patterns were identified and compared with the 2020 ACR guidelines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Contraception documentation rates were similar in the prepandemic and mid-pandemic groups (8.1% and 8.5%, respectively). Higher documentation rates were found in women who were younger, White, and had more visits, as well as those seen within a health system, by a female provider, and within specific regions and electronic health record (EHR) systems. Prescription of a teratogenic medication did not influence contraception documentation or type. Oestrogen-containing contraceptives were prescribed less often to women at high risk for thrombosis (26.2% with thrombotic risk vs 60.6% without, p&lt;0.0001) and history of lupus nephritis (LN) (53.8% with history of LN vs 63.2% without, p=0.024).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Practices participating in the RISE registry do not currently record contraception in the large majority of women with SLE, although increased documentation in some EHRs suggests that system changes may improve rates of documentation. Women at higher risk for thrombosis were less likely to receive oestrogen, suggesting that warnings against oestrogen use has impacted contraception prescription, although the limited documentation and limited contraception among women taking teratogenic medications suggest a high unmet need.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2024-001192","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:53:22Z","timestamp":1724475202000},"page":"e001192","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Alignment of contraception use with the ACR reproductive health guidelines in women with systemic lupus erythematosus within the RISE registry"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-3470","authenticated-orcid":false,"given":"Megan E B","family":"Clowse","sequence":"first","affiliation":[{"name":"Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1306-1429","authenticated-orcid":false,"given":"Amanda","family":"Snyderman","sequence":"additional","affiliation":[{"name":"Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Schmajuk","sequence":"additional","affiliation":[{"name":"Medicine, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"2025091513081607000_11.2.e001192.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20864"},{"key":"2025091513081607000_11.2.e001192.2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2025091513081607000_11.2.e001192.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211641"},{"key":"2025091513081607000_11.2.e001192.4","first-page":"342","article-title":"Maternal and foetal outcomes in pregnant patients with active lupus nephritis","volume":"18","author":"Wagner","year":"2009","journal-title":"Lupus (Los Angel)"},{"key":"2025091513081607000_11.2.e001192.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.07.010"},{"key":"2025091513081607000_11.2.e001192.6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/acr.24803","article-title":"Frequency of contraception documentation in women with systemic lupus erythematosus and rheumatoid arthritis within the rheumatology informatics system for effectiveness registry","volume":"75","author":"Clowse","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513081607000_11.2.e001192.7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/AOG.0000000000000279","article-title":"Receipt of prescription contraception by commercially insured women with chronic medical conditions","volume":"123","author":"DeNoble","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2025091513081607000_11.2.e001192.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.23712"},{"key":"2025091513081607000_11.2.e001192.9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/acr.20402","article-title":"Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?","volume":"63","author":"Yazdany","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513081607000_11.2.e001192.10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/acr.23724","article-title":"Contraception use among reproductive-age women with rheumatic diseases","volume":"71","author":"Birru Talabi","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513081607000_11.2.e001192.11","first-page":"293","article-title":"Contraceptive prevalence and consulting service in women with systemic lupus erythematosus: a cross-sectional study","volume":"31","author":"Mobini","year":"2021","journal-title":"Ethiop J Health Sci"},{"key":"2025091513081607000_11.2.e001192.12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025091513081607000_11.2.e001192.13","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/acr.23089","article-title":"Rheumatology informatics system for effectiveness: a national informatics-enabled registry for quality improvement","volume":"68","author":"Yazdany","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513081607000_11.2.e001192.14","doi-asserted-by":"publisher","DOI":"10.1363\/psrh.12017"},{"key":"2025091513081607000_11.2.e001192.15","unstructured":"Wisconsin Uo . 2018. Available: https:\/\/www.neighborhoodatlas.medicine.wisc.edu\/2023"},{"key":"2025091513081607000_11.2.e001192.16","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90133-8"},{"key":"2025091513081607000_11.2.e001192.17","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocaa067"},{"key":"2025091513081607000_11.2.e001192.18","doi-asserted-by":"crossref","unstructured":"So H , Chow E , Cheng IT , et al . Telemedicine for follow-up of systemic lupus erythematosus during the 2019 coronavirus pandemic: A pragmatic randomized controlled trial. J Telemed Telecare 2023. doi:10.1177\/1357633X231181714","DOI":"10.1177\/1357633X231181714"},{"key":"2025091513081607000_11.2.e001192.19","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/acr.24346","article-title":"Racial differences in contraception encounters and dispensing among female medicaid beneficiaries with systemic lupus erythematosus","volume":"73","author":"Williams","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091513081607000_11.2.e001192.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.01.037"},{"key":"2025091513081607000_11.2.e001192.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2017.07.007"},{"key":"2025091513081607000_11.2.e001192.22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/13557858.2018.1439896","article-title":"Gendered racism and the sexual and reproductive health of black and latina women","volume":"25","author":"Rosenthal","year":"2020","journal-title":"Ethn Health"},{"key":"2025091513081607000_11.2.e001192.23","unstructured":"Kimberly D , Joyce A . Current contraceptive status among women aged 15\u201349: United States, 2017\u20132019. NCHS Data Brief; 2020."},{"key":"2025091513081607000_11.2.e001192.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2005.03.005"},{"key":"2025091513081607000_11.2.e001192.25","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/rheumatology\/kez014","article-title":"Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen","volume":"58","author":"Mendel","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2025091513081607000_11.2.e001192.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050817"},{"key":"2025091513081607000_11.2.e001192.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051135"},{"key":"2025091513081607000_11.2.e001192.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"key":"2025091513081607000_11.2.e001192.29","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.134882"},{"key":"2025091513081607000_11.2.e001192.30","first-page":"877","article-title":"Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil)","volume":"15","author":"Pisoni","year":"2006","journal-title":"Lupus (Los Angel)"},{"key":"2025091513081607000_11.2.e001192.31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"2025091513081607000_11.2.e001192.32","unstructured":"Cellcept (mycophenolate mofetil) prescribing information. 2019."},{"key":"2025091513081607000_11.2.e001192.33","first-page":"203","article-title":"Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic","volume":"24","author":"Quinzanos","year":"2015","journal-title":"Lupus (Los Angel)"},{"key":"2025091513081607000_11.2.e001192.34","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-017-2283-2"},{"key":"2025091513081607000_11.2.e001192.35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2018.08.014","article-title":"Beyond intent: exploring the association of contraceptive choice with questions about pregnancy attitudes, timing and how important is pregnancy prevention (PATH) questions","volume":"99","author":"Geist","year":"2019","journal-title":"Contraception"},{"key":"2025091513081607000_11.2.e001192.36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/acr2.11449","article-title":"Pregnancy intention screening in patients with systemic rheumatic diseases: pilot testing a standardized assessment tool","volume":"4","author":"Pryor","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"2025091513081607000_11.2.e001192.37","first-page":"1666","article-title":"The impact of pregnancy planning and medical readiness on reproductive outcomes in women with systemic lupus erythematosus","volume":"32","author":"Sims","year":"2023","journal-title":"Lupus (Los Angel)"},{"key":"2025091513081607000_11.2.e001192.38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MLR.0000000000000908","article-title":"Quality of primary care provided to medicare beneficiaries by nurse practitioners and physicians","volume":"56","author":"Buerhaus","year":"2018","journal-title":"Med Care"},{"key":"2025091513081607000_11.2.e001192.39","doi-asserted-by":"crossref","DOI":"10.1186\/s12910-017-0179-8","article-title":"Implicit bias in healthcare professionals: a systematic review","volume":"18","author":"FitzGerald","year":"2017","journal-title":"BMC Med Ethics"},{"key":"2025091513081607000_11.2.e001192.40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/heq.2017.0045","article-title":"Racism, African American women, and their sexual and reproductive health: a review of historical and contemporary evidence and implications for health equity","volume":"2","author":"Prather","year":"2018","journal-title":"Health Equ"},{"key":"2025091513081607000_11.2.e001192.41","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.7326\/M22-2246","article-title":"Unintended consequences of SCOTUS abortion decision for patients with rheumatic diseases","volume":"175","author":"Clowse","year":"2022","journal-title":"Ann Intern Med"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2024-001192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:08:24Z","timestamp":1757966904000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2024-001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8,24]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1136\/lupus-2024-001192"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2024-001192","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}